Amneal Pharmaceuticals (AMRX) News Today → Most people would never touch this orange powder… would you? (From DTI) (Ad) Free AMRX Stock Alerts $6.75 +0.06 (+0.90%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 9 at 11:55 AM | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Purchased by Rubric Capital Management LPRubric Capital Management LP increased its stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 98.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,000,000 shares of the company's stocJune 5, 2024 | businesswire.comAmneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New TherapiesMay 29, 2024 | marketbeat.com212,700 Shares in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Purchased by Swiss National BankSwiss National Bank acquired a new stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 212,700 shares of the company's stock, valued at approximately $1,291,000. Swiss National BMay 28, 2024 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Shares Up 6.4%Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Up 6.4%May 27, 2024 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus Recommendation of "Buy" by BrokeragesShares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) have earned an average rating of "Buy" from the four research firms that are currently covering the firm, MarketBeat reports. Four equities research analysts have rated the stock with a buy recommendation. The average 1-year taMay 22, 2024 | marketwatch.comAmneal Pharmaceuticals Begins Supplying Generic Version of NarcanMay 22, 2024 | businesswire.comAmneal to Participate at Upcoming Investor ConferenceMay 22, 2024 | businesswire.comAmneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of CaliforniaMay 20, 2024 | marketbeat.comAssenagon Asset Management S.A. Raises Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Assenagon Asset Management S.A. boosted its stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 271.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 546,537 shares of the company's stock after buying anMay 20, 2024 | finance.yahoo.comInsider Sale: Director Deborah Autor Sells 38,000 Shares of Amneal Pharmaceuticals Inc (AMRX)May 15, 2024 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Hits New 1-Year High at $6.95Amneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 52-Week High at $6.95May 14, 2024 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Sees Large Drop in Short InterestAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) was the recipient of a large decline in short interest in April. As of April 30th, there was short interest totalling 2,370,000 shares, a decline of 15.4% from the April 15th total of 2,800,000 shares. Based on an average trading volume of 1,620,000 shares, the short-interest ratio is currently 1.5 days. Approximately 2.3% of the company's stock are short sold.May 13, 2024 | markets.businessinsider.comBarclays Reaffirms Their Buy Rating on Amneal Pharmaceuticals (AMRX)May 9, 2024 | marketbeat.comLSV Asset Management Has $6.61 Million Stock Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)LSV Asset Management decreased its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 23.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,089,300 shares of thMay 6, 2024 | markets.businessinsider.comAssessing Amneal Pharmaceuticals: Insights From 4 Financial AnalystsMay 6, 2024 | finance.yahoo.comAmneal Pharmaceuticals First Quarter 2024 Earnings: US$0.30 loss per share (vs US$0.046 loss in 1Q 2023)May 6, 2024 | marketbeat.comThe Goldman Sachs Group Boosts Amneal Pharmaceuticals (NASDAQ:AMRX) Price Target to $8.00The Goldman Sachs Group upped their target price on Amneal Pharmaceuticals from $6.25 to $8.00 and gave the stock a "buy" rating in a report on Monday.May 6, 2024 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Stock Rating Reaffirmed by Truist FinancialTruist Financial restated a "buy" rating and issued a $9.00 target price (up previously from $7.00) on shares of Amneal Pharmaceuticals in a research report on Monday.May 6, 2024 | markets.businessinsider.comAmneal Pharmaceuticals: A Strong Buy on Robust Growth and Promising PipelineMay 4, 2024 | msn.comAmneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2024 Earnings Call TranscriptMay 4, 2024 | finance.yahoo.comAmneal Pharmaceuticals Inc (AMRX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...May 3, 2024 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Hits New 12-Month High at $6.90Amneal Pharmaceuticals (NASDAQ:AMRX) Hits New 12-Month High at $6.90May 3, 2024 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Issues FY 2024 Earnings GuidanceAmneal Pharmaceuticals (NASDAQ:AMRX) updated its FY 2024 earnings guidance. The company provided EPS guidance of 0.530-0.630 for the period, compared to the consensus estimate of 0.580. The company also issued revenue guidance of $2.6 billionillion-$2.7 billionillion, compared to the consensus estimate of $2.6 billionillion.May 3, 2024 | msn.comGeneric Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit SettlementMay 3, 2024 | msn.comAmneal stock climbs on Q1 report, opioid settlement updateMay 3, 2024 | seekingalpha.comAmneal Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call PresentationMay 3, 2024 | msn.comAMRX Stock Earnings: Amneal Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024May 3, 2024 | reuters.comDrugmaker Amneal agrees to $270 million U.S. opioid settlementMay 3, 2024 | washingtonpost.comAmneal: Q1 Earnings SnapshotMay 3, 2024 | businesswire.comAmneal Reports First Quarter 2024 Financial ResultsMay 2, 2024 | msn.comAmneal Pharmaceuticals Q1 2024 Earnings PreviewMay 2, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Amneal Pharmaceuticals (AMRX)April 30, 2024 | msn.comCalifornia is joining with a New Jersey company to make a generic opioid overdose reversal drugApril 30, 2024 | msn.comCalifornia teams with Amneal Pharma for cheaper, generic version of NarcanApril 29, 2024 | msn.comCalifornia is joining with a New Jersey company to buy a generic opioid overdose reversal drugApril 25, 2024 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Trading Down 7.1%Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Down 7.1%April 25, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Sells 146,925 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Allspring Global Investments Holdings LLC lessened its stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 51.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 137,764 sharesApril 24, 2024 | marketwatch.comAmneal Pharmaceuticals Shares Rise 9% After FDA Approves Naloxone SprayApril 24, 2024 | markets.businessinsider.comAmneal's OTC Naloxone Nasal Spray Receives FDA Approval For Opioid Overdose Emergency TreatmentApril 24, 2024 | businesswire.comAmneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid OverdoseApril 16, 2024 | businesswire.comAmneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable MedicineApril 15, 2024 | finance.yahoo.comAmneal Pharmaceuticals (NASDAQ:AMRX) shareholders are still up 235% over 1 year despite pulling back 8.0% in the past weekApril 14, 2024 | marketbeat.comPhocas Financial Corp. Buys Shares of 714,890 Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Phocas Financial Corp. bought a new stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 714,890 shares of the company's stock, valued at approximately $4,339,0April 14, 2024 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Up 15.9% in MarchAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 2,400,000 shares, a growth of 15.9% from the March 15th total of 2,070,000 shares. Based on an average daily volume of 1,530,000 shares, the days-to-cover ratio is currently 1.6 days. Currently, 2.2% of the company's stock are sold short.April 11, 2024 | finance.yahoo.comAlkermes' Innovations Are Transforming Mental Health TreatmentsApril 10, 2024 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Up 1.9%Amneal Pharmaceuticals (NASDAQ:AMRX) Trading Up 1.9%April 10, 2024 | businesswire.comAmneal to Report First Quarter 2024 Results on May 3, 2024April 9, 2024 | stocknews.com3 Lucrative Pharma Stocks to Diversify Your InvestmentsApril 9, 2024 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Down 2.2%Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Down 2.2%April 8, 2024 | msn.comBausch Health drops after suing Amneal Pharma over Xifaxan generic Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address 3 Dirt-Cheap Stocks You Can’t Afford to Ignore (Ad)Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances. Get your FREE look at these THREE companies right here. AMRX Media Mentions By Week AMRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMRX News Sentiment▼0.000.76▲Average Medical News Sentiment AMRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMRX Articles This Week▼23▲AMRX Articles Average Week Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AMPH News Today COLL News Today INZY News Today FHTX News Today EGRX News Today ASND News Today CERE News Today LEGN News Today ITCI News Today VKTX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMRX) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored